Mindfulness to Enhance Quality of Life and Support Advance Care Planning (MEANING): A Randomized Controlled Pilot Trial for Adults With Metastatic Cancer and Their Family Caregivers
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Mindfulness
- Sponsor
- Indiana University
- Enrollment
- 108
- Locations
- 1
- Primary Endpoint
- Change from baseline in quality of life (QoL) for Patients
- Status
- Completed
- Last Updated
- 5 years ago
Overview
Brief Summary
The MEANING trial is a randomized controlled mixed methods pilot designed to compare a novel mindfulness meditation-based intervention (MEANING) to usual care for adults with advanced-stage solid malignancies and their family caregivers.
Detailed Description
Mindfulness meditation practices have reduced emotional distress, avoidant coping, and improved spiritual well-being in adult cancer patients. These beneficial effects may occur through present-moment acceptance of unpleasant thoughts, feelings, and circumstances and adaptive coping through self-awareness, self-regulation, and self-transcendence. Most mindfulness trials in cancer have focused on early-stage survivors; however, preliminary evidence suggests that mindfulness may help reduce distress in patients with advanced cancer and their family caregivers (FCGs). Sixty patients with an advanced-stage solid malignancy and their FCGs (60 dyads) will be randomized in equal numbers to receive either the 6-week mindfulness intervention or usual care. Both groups will receive standard cancer care throughout the study period. Dyads randomized to the mindfulness arm will learn mindfulness meditation practices (e.g., body scan, sitting meditation) and mindful communication practices to enhance quality of life, support advance care planning engagement, and improve a variety of secondary outcomes. The study will use a mixed methods 2-arm randomized design to examine the effects of the mindfulness intervention compared to usual care and seek to explain trial results using insights gleaned from post-intervention qualitative interviews.
Investigators
Shelley Johns
Assistant Professor of Medicine, Research Scientist
Indiana University
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Change from baseline in quality of life (QoL) for Patients
Time Frame: Baseline, 6 weeks, and 10 weeks
QoL for patients will be assessed with the McGill Quality of Life Inventory.
Change from baseline in quality of life (QoL) for Family Caregivers
Time Frame: Baseline, 6 weeks, and 10 weeks
QoL for family caregivers will be assessed with the Caregiver Quality of Life - Cancer scale (CQoLC).
Secondary Outcomes
- Change from baseline in advance care planning (ACP) engagement(Baseline, 6 weeks, and 10 weeks)
- Change from baseline in family communication(Baseline, 6 weeks, and 10 weeks)
- Change from baseline in caregiver burden(Baseline, 6 weeks, and 10 weeks)
- Change from baseline in advance care planning (ACP) stage of change(Baseline, 6 weeks, and 10 weeks)
- Change from baseline in anxiety(Baseline, 6 weeks, and 10 weeks)
- Intervention satisfaction and helpfulness(6 weeks)
- Change from baseline in avoidant coping(Baseline, 6 weeks, and 10 weeks)
- Change from baseline in depressive symptoms(Baseline, 6 weeks, and 10 weeks)
- Change from baseline in spiritual well-being(Baseline, 6 weeks, and 10 weeks)
- Change from baseline in sleep disturbance(Baseline, 6 weeks, and 10 weeks)
- Change from baseline in acceptance of illness(Baseline, 6 weeks, and 10 weeks)
- Change from baseline in mindfulness(Baseline, 6 weeks, and 10 weeks)
- Change from baseline in interpersonal closeness(Baseline, 6 weeks, and 10 weeks)
- Distress Thermometer(Baseline, 6 weeks, and 10 weeks)